How to Get Semaglutide for Weight Loss in the UK

Prescription required by law: semaglutide for weight loss is a Prescription-Only Medicine; the brand licensed for this purpose in the UK is Wegovy, not Ozempic, which is licensed for type 2 diabetes.
Two legitimate routes: NHS specialist weight management services (long waiting lists, strict criteria) or a regulated private pharmacy with a GPhC-registered prescriber conducting a real clinical review.
Identity and weight are verified: any reputable service confirms who you are and your current weight before issuing a prescription; photo-ID checks and live video weight verification are standard practice at responsible providers.
Starting dose is 0.25mg weekly: semaglutide for weight management begins at a low tolerability dose, titrated upward by your prescriber over several months toward the 2.4mg (or higher) maintenance dose.

Getting semaglutide for weight loss in the UK means obtaining a prescription following a clinical assessment — it is a Prescription-Only Medicine and cannot be legally supplied without one. The licensed product for weight management is Wegovy, and a prescriber (not an algorithm, not an automated questionnaire) decides whether it is suitable for you based on your full health picture. Here is a clear account of how that process works, which route makes sense for your situation, and what to watch for along the way.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Three decisions that shape how you actually get semaglutide

NHS or private? The honest breakdown

Most people searching for semaglutide have already heard that it is available on the NHS and are wondering why they cannot simply ask their GP. The short answer is that NHS access is real but narrow. Under NICE's appraisal of semaglutide (TA875), Wegovy is recommended only through specialist weight management services, for a maximum of two years, and only for adults with a BMI of 35 or above who also have at least one weight-related condition. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Waiting lists for those specialist services run to months or years in most areas, and the criteria exclude many people who are still genuinely affected by excess weight.

Private prescribing is the other path. A GPhC-registered online pharmacy with independent prescribers can assess you, issue a private prescription and dispense Wegovy from the licensed UK supply chain, typically within a day. The cost sits with you, and that is worth factoring in early — our semaglutide cost guide explains what private treatment typically involves financially.

Neither route is inherently superior; it depends on your eligibility, how long you are willing to wait and what ongoing clinical support matters to you.

What makes you eligible, and who decides

A common misconception is that BMI alone unlocks a prescription. It does not. The licensed indication for Wegovy covers adults with a BMI of 30 or above, or 27 to 29.9 with at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea or prediabetes. But meeting those numbers is the floor, not the ceiling. A prescriber also considers your medical history, current medicines, any contraindications (such as a personal or family history of certain thyroid conditions), and whether your goals are realistic and safe to pursue with this treatment.

That assessment is the reason semaglutide cannot be sold freely. It is also the reason a thorough consultation protects you. On the step-by-step Wegovy access guide we go deeper into what a responsible clinical review covers, including how prescribers approach dose increases and transfer patients coming from another provider.

If you are not sure where you stand on eligibility, the NHS BMI calculator gives you your starting figure; bring that and a list of any current medicines to your consultation.

What the process looks like from consultation to delivery

Assuming you go through a regulated private pharmacy, the sequence is straightforward. You complete a clinical questionnaire; a GPhC-registered independent prescriber reads your answers personally and either approves the prescription, asks follow-up questions or, where treatment is not appropriate, tells you clearly why. Photo-ID verification and live video weight confirmation happen before anything is dispensed.

Once approved, the medicine ships from the pharmacy's own MHRA-regulated dispensing operation, tracked, in plain unbranded packaging. The semaglutide overview covers what arrives, how to store it and what the first few weeks tend to feel like. Subsequent supplies are not automatic, a prescriber reviews the clinical picture again before each repeat, which is both a legal requirement and a meaningful safety check.

If you are already on treatment elsewhere and considering a switch, the guide to obtaining Wegovy through a regulated pharmacy explains what evidence transfers typically require. And if at any point you want to stop treatment rather than continue, stepping down from Wegovy is something to plan with your prescriber rather than do abruptly.

Red flags and how to spot a risky seller

The MHRA has warned publicly and repeatedly about fake weight-loss pens sold online and through social media. Counterfeit pens seized in the UK have contained insulin rather than semaglutide, causing serious harm. The enforcement pattern is consistent: sellers offering these medicines without a prescription, prices far below anything a licensed pharmacy could offer, and no verifiable GPhC registration. Any seller offering Wegovy at a price that seems implausibly low, or without requiring a clinical assessment, is a serious red flag.

Checking a pharmacy's GPhC registration takes under a minute at the GPhC pharmacy register. You can also report a suspect seller directly via the MHRA's Yellow Card scheme. These steps are worth taking before handing over payment or health information to any provider you have not verified.

If you want to understand more about what the full treatment journey looks like (lifestyle changes, what to expect alongside the medicine, and how clinical oversight works in practice) the weight-loss treatment overview covers the broader picture. When you are ready to talk through your own situation, speak to our prescribers through a free consultation and get a clinical view on whether semaglutide is appropriate for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions